RBP4 and metabolic dysfunction-associated steatotic liver disease: Yang et al. reported that after 12 weeks of treatment with pioglitazone or metformin, pioglitazone was superior to metformin for decreasing RBP4 levels and HOMA-IR in patients with T2DM complicated with NAFLD [124].